99
Views
4
CrossRef citations to date
0
Altmetric
Original Article: Research

Inhibition of class II phosphoinositide 3-kinase γ expression by p185Bcr–Abl contributes to impaired chemotaxis and aberrant homing of leukemic cells

, , , &
Pages 1098-1107 | Received 20 Dec 2009, Accepted 06 Mar 2010, Published online: 10 Jun 2010
 

Abstract

The expression of p185Bcr–Abl in Ba/F3 cells inhibits the chemotactic response of these cells to SDF1α. A mutant p185Bcr–Abl with deletion of amino acids from 176 to 426 (p185Δ176–426) is deficient in suppressing SDF1α-stimulated chemotaxis. Comparison of the gene expression profiles among parental Ba/F3 cells and cells transformed by p185Bcr–Abl and p185Δ176–426 reveals that class II phosphoinositide 3-kinase γ (PI3KC2γ) expression is markedly down-regulated by p185Bcr–Abl but not p185Δ176–426. Furthermore, knockdown of PI3KC2γ expression in p185Δ176–426 cells is sufficient to suppress SDF1α-stimulated chemotaxis and to promote infiltration of these cells into the liver. Together, these studies suggest that inhibition of PI3KC2γ expression may represent a mechanism by which Bcr–Abl suppresses SDF1α-induced chemotaxis and induces abnormal homing of leukemic cells.

Acknowledgements

We thank Drs. Yingzhu Li and Vishakha Kale for assistance in the migration assay, Dr. Bifeng Gao for DNA microarray analysis, and Dr. William C. Gilmore for pathology/histology analysis.

Declaration of Interest:This work was supported in part by a grant from the National Cancer Institute (R01 CA094921; Z.D.), a grant from the When Everyone Survives Foundation (Z.D.), and a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (grant K01 DK067191; Y.T.).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.